Diagnostic and Prognostic Values of Plasma Levels of Fibrinolytic Markers in Gastric Cancer
- 1 July 1998
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 91 (1) , 23-27
- https://doi.org/10.1016/s0049-3848(98)00061-9
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Prognostic value of the plasminogen activation system in patients with gastric carcinomaCancer, 1996
- Prognostic relevance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in gastric cancerVirchows Archiv, 1996
- The prognostic impact of the urokinase-type plasminogen activator system is associated with tumour differentiation in gastric cancerEuropean Journal of Surgical Oncology, 1996
- E-cadherin and urokinase-type plasminogen activator tissue status in gastric carcinomaCancer, 1995
- Cysteine and serine proteases in gastric cancerCancer, 1995
- Fibrinolytic markers of clinical evolution in tumour patientsFibrinolysis, 1993
- Urokinase and urokinase receptor: a paracrinelautocrine system regulating cell migration and invasivenessFibrinolysis, 1993
- Biological evaluation of the fibrinolytic systemFibrinolysis, 1993
- Possible role of plasminogen activator inhibitor 2 in the prevention of the metastasis of gastric cancer tissuesThrombosis Research, 1992
- Measurement of protein using bicinchoninic acidAnalytical Biochemistry, 1985